Covid-19
Bloomington facility to help make COVID-19 vaccine
INDIANAPOLIS — A major pharmaceutical company with operations in central Indiana will help make a possible vaccine for the coronavirus.
Catalent has signed an agreement to manufacture Johnson & Johnson’s lead vaccine candidate for COVID-19 in the United States.
The company will use it’s 875,000-square-foot facility in Bloomington for the operation.
Johnson & Johnson has been working on a coronavirus vaccine since January. They hope to start clinical trials by September at the latest. Plans call for Catalent to hire about 300 additional employees in Bloomington to help get the vaccine to Americans.
“We’re happy that we’re able to help the community, and really, I think the employees are very engaged and feel good about the fact that we’re working on something impacts everybody around them,” said Denis Johnson, vice president and general manager of Catalent in Bloomington.
Catalent says they are looking to start the manufacturing process in July with the ability to run around the clock by January.
-
Local News2 weeks ago
$50,000 Truck stop sells Powerball tickets that are about to expire
-
Local News2 weeks ago
Behold the spectacle that is Good Gravy!
-
Indiana2 weeks ago
Anderson man sentenced to 65 years for wife murder
-
Indiana2 weeks ago
Woman from Aurora detained for assaulting a child
-
Local News2 weeks ago
$75 million “luxury urban” townhomes and condos with rooftop terraces are set to begin construction
-
Local News2 weeks ago
Indiana Health Department is sued by an anti-abortion group seeking access to abortion records
-
Local News1 week ago
$50,000 Powerball Double Play ticket sold in Indiana
-
Local News1 week ago
Voters choose Democrats Munson, Deckard, Henry in county council primary
Leave a Reply